Your browser doesn't support javascript.
loading
GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy.
Sissung, Tristan M; Lochrin, Sarah; Liu, Tyler; Schmidt, Keith; Strope, Jonathan; Risdon, Emily; Choo-Wosoba, Hyoyoung; Venzon, David J; Lassoued, Wiem; Sater, Houssein A; Walter-Rodriguez, Beatriz; Price, Douglas K; Figg, William D.
Affiliation
  • Sissung TM; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Lochrin S; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Liu T; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Schmidt K; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Strope J; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Risdon E; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Choo-Wosoba H; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Venzon DJ; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Lassoued W; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Sater HA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Walter-Rodriguez B; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Price DK; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.
  • Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A. figgw@mail.nih.gov.
Anticancer Res ; 43(9): 4023-4030, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37648321

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Prostatic Neoplasms Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Prostatic Neoplasms Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2023 Document type: Article Affiliation country: Country of publication: